Petar Mas
Zagreb, Croatia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Duplicate Detection Will Advance with Technology: Yet Underreporting Remains the Core Challenge.
Journal: Hospital pharmacy
Published: October 20, 2025
Anti-amyloid antibodies in Europe: Where are we now?
Journal: British journal of clinical pharmacology
Published: September 30, 2025
Diverging Safety Signals: A Trend Analysis of Suspected Adverse Drug Reactions Reporting for Spinal Muscular Atrophy Therapies in the European Union.
Journal: Neurology international
Published: September 02, 2025
Post-Marketing Safety of Spinal Muscular Atrophy Therapies: Analysis of Spontaneous Adverse Drug Reactions from EudraVigilance.
Journal: Journal of clinical medicine
Published: April 07, 2025
Analysis of spontaneous reporting of suspected adverse drug reactions for non-analgesic over-the-counter drugs from 2008 to 2017.
Journal: BMC pharmacology & toxicology
Published: March 19, 2019
Genetic polymorphisms of cytochrome P450 enzymes: CYP2C9, CYP2C19, CYP2D6, CYP3A4, and CYP3A5 in the Croatian population.
Journal: Drug metabolism and personalized therapy
Published: October 12, 2016
Integrating Pharmacovigilance and Pharmacogenomics: Croatian Experience.
Journal: Clinical therapeutics
Published: September 28, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026